{"id":6166,"date":"2023-01-29T07:57:00","date_gmt":"2023-01-29T15:57:00","guid":{"rendered":"https:\/\/allocare.caredx.com\/?p=6166"},"modified":"2023-01-26T08:02:37","modified_gmt":"2023-01-26T16:02:37","slug":"diabetes-drug-for-cats-now-approved-in-humans-too","status":"publish","type":"post","link":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/indexphp\/post\/2023\/01\/29\/diabetes-drug-for-cats-now-approved-in-humans-too\/","title":{"rendered":"Diabetes Drug for Cats Now Approved in Humans Too"},"content":{"rendered":"<span class=\"simplefavorite-button has-count loading\" data-postid=\"6166\" data-siteid=\"1\" data-groupid=\"1\" data-favoritecount=\"0\" style=\"\">Loading<span class=\"sf-icon-spinner-wrapper\"><i class=\"sf-icon-spinner\"><\/i><\/span><\/span>\n<h2 class=\"wp-block-heading\"><em>\u2014 Oral SGLT2 inhibitor bexagliflozin indicated for adults with type 2 diabetes<\/em><\/h2>\n\n\n\n<p>The first oral SGLT2 inhibitor approved by the FDA for treating diabetes in\u00a0<a rel=\"noreferrer noopener\" href=\"https:\/\/www.fda.gov\/animal-veterinary\/cvm-updates\/fda-approves-first-oral-treatment-cats-diabetes-mellitus\" target=\"_blank\">cats opens in a new tab or window<\/a>\u00a0is now approved for humans with the disease<a rel=\"noreferrer noopener\" href=\"https:\/\/www.businesswire.com\/news\/home\/20230123005126\/en\/TheracosBio-Announces-FDA-Approval-of-Brenzavvy%E2%84%A2-bexagliflozin-for-the-Treatment-of-Adults-with-Type-2-Diabetes\" target=\"_blank\">, drugmaker TheracosBios announced.<\/a><\/p>\n\n\n\n<p>As an adjunct to diet and exercise, the oral treatment is indicated for adults with type 2 diabetes, and is not recommended for those with type 1 diabetes or for patients in diabetic ketoacidosis, according to the company. <a href=\"https:\/\/www.medpagetoday.com\/endocrinology\/diabetes\/102754?xid=nl_mpt_morningbreak2023-01-24&amp;eun=g2017571d0r&amp;utm_source=Sailthru&amp;utm_medium=email&amp;utm_campaign=MorningBreak_012423&amp;utm_term=NL_Gen_Int_Daily_News_Update_active\">Read the full story <\/a>in Medpage Today.<\/p>\n<span class=\"simplefavorite-button has-count loading\" data-postid=\"6166\" data-siteid=\"1\" data-groupid=\"1\" data-favoritecount=\"0\" style=\"\">Loading<span class=\"sf-icon-spinner-wrapper\"><i class=\"sf-icon-spinner\"><\/i><\/span><\/span>","protected":false},"excerpt":{"rendered":"<p>Loading \u2014 Oral SGLT2 inhibitor bexagliflozin indicated for adults with type 2 diabetes The first oral SGLT2 inhibitor approved by the FDA for treating diabetes in\u00a0cats opens in a new &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/indexphp\/post\/2023\/01\/29\/diabetes-drug-for-cats-now-approved-in-humans-too\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Diabetes Drug for Cats Now Approved in Humans Too&#8221;<\/span><\/a><\/p>\n","protected":false},"author":208,"featured_media":3258,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":0,"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_tribe_blocks_recurrence_rules":"","_tribe_blocks_recurrence_description":"","_tribe_blocks_recurrence_exclusions":"","_ecp_custom_2":"","footnotes":""},"categories":[45,489],"tags":[712],"post_format":[],"Dislikes":"","Likes":"","simplefavorites_count":"","views":"1338","post_likes_plusCounter":"2","post_dislikes_plusCounter":"","acf":[],"_links":{"self":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts\/6166"}],"collection":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/users\/208"}],"replies":[{"embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/comments?post=6166"}],"version-history":[{"count":1,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts\/6166\/revisions"}],"predecessor-version":[{"id":6167,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts\/6166\/revisions\/6167"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/media\/3258"}],"wp:attachment":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/media?parent=6166"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/categories?post=6166"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/tags?post=6166"},{"taxonomy":"post_format","embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/post_format?post=6166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}